{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:16:44Z","timestamp":1788675404742,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.7759\/cureus.99526","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:12:31Z","timestamp":1766052751000},"source":"Crossref","is-referenced-by-count":1,"title":["Invasive Infection With Purpureocillium lilacinum: A Case of Fungal Peritonitis"],"prefix":"10.7759","author":[{"given":"John M","family":"West","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissete","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2011.02322.x","article-title":"Purpureocillium, a new genus for the medically important Paecilomyces lilacinus","volume":"321","author":"Luangsa-Ard J","year":"2011","unstructured":"Luangsa-Ard J, Houbraken J, van Doorn T, Hong SB, Borman AM, Hywel-Jones NL, Samson RA. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett. 2011, 321:141-9. 10.1111\/j.1574-6968.2011.02322.x","journal-title":"FEMS Microbiol Lett"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01481.x","article-title":"Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections","volume":"12","author":"Pastor FJ","year":"2006","unstructured":"Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect. 2006, 12:948-60. 10.1111\/j.1469-0691.2006.01481.x","journal-title":"Clin Microbiol Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.2008\/001149-0","article-title":"Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy","volume":"57","author":"Chang BP","year":"2008","unstructured":"Chang BP, Sun PL, Huang FY, et al.. Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy. J Med Microbiol. 2008, 57:1581-4. 10.1099\/jmm.0.2008\/001149-0","journal-title":"J Med Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/089686081203200301","article-title":"Paecilomyces lilacinus peritonitis in a peritoneal dialysis patient","volume":"32","author":"Wolley M","year":"2012","unstructured":"Wolley M, Collins J, Thomas M. Paecilomyces lilacinus peritonitis in a peritoneal dialysis patient. Perit Dial Int. 2012, 32:364-5. 10.1177\/089686081203200301","journal-title":"Perit Dial Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab039","article-title":"Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope\u00ae and the literature","volume":"76","author":"Sprute R","year":"2021","unstructured":"Sprute R, Salmanton-Garc\u00eda J, Sal E, et al.. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope\u00ae and the literature. J Antimicrob Chemother. 2021, 76:1593-603. 10.1093\/jac\/dkab039","journal-title":"J Antimicrob Chemother"},{"key":"ref6","article-title":"[Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis]","volume":"29","author":"Garc\u00eda-Agudo R","year":"2009","unstructured":"Garc\u00eda-Agudo R, Garc\u00eda-Martos P. [Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis]. Nefrologia. 2009, 29:506-17.","journal-title":"Nefrologia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101230","article-title":"Practical issues related to non-Aspergillus invasive mold infections","volume":"94","author":"Nucci M","year":"2023","unstructured":"Nucci M, Nou\u00e9r SA. Practical issues related to non-Aspergillus invasive mold infections. Mol Aspects Med. 2023, 94:101230. 10.1016\/j.mam.2023.101230","journal-title":"Mol Aspects Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00538-08","article-title":"Susceptibility testing and molecular classification of Paecilomyces spp","volume":"52","author":"Castelli MV","year":"2008","unstructured":"Castelli MV, Alastruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother. 2008, 52:2926-8. 10.1128\/AAC.00538-08","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jof8070684","article-title":"Species identification and in vitro antifungal susceptibility of Paecilomyces\/Purpureocillium species isolated from clinical respiratory samples: a multicenter study","volume":"8","author":"Monpierre L","year":"2022","unstructured":"Monpierre L, A\u00eft-Ammar N, Valsecchi I, et al.. Species identification and in vitro antifungal susceptibility of Paecilomyces\/Purpureocillium species isolated from clinical respiratory samples: a multicenter study. J Fungi (Basel). 2022, 8:684. 10.3390\/jof8070684","journal-title":"J Fungi (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl M","year":"2021","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, et al.. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis. 2021, 21:e246-57. 10.1016\/S1473-3099(20)30784-2","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i10.1772","article-title":"Successful treatment of Purpureocillium lilacinum pulmonary infection with isavuconazole: a case report","volume":"12","author":"Yang XL","year":"2024","unstructured":"Yang XL, Zhang JY, Ren JM. Successful treatment of Purpureocillium lilacinum pulmonary infection with isavuconazole: a case report. World J Clin Cases. 2024, 12:1772-7. 10.12998\/wjcc.v12.i10.1772","journal-title":"World J Clin Cases"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (secure): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens JA","year":"2016","unstructured":"Maertens JA, Raad II, Marr KA, et al.. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (secure): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016, 387:760-9. 10.1016\/S0140-6736(15)01159-9","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes D","year":"2018","unstructured":"Andes D, Kovanda L, Desai A, Kitt T, Zhao M, Walsh TJ. Isavuconazole concentration in real-world practice: consistency with results from clinical trials. Antimicrob Agents Chemother. 2018, 62:e00585-18. 10.1128\/AAC.00585-18","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439878-invasive-infection-with-purpureocillium-lilacinum-a-case-of-fungal-peritonitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:12:33Z","timestamp":1766052753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439878-invasive-infection-with-purpureocillium-lilacinum-a-case-of-fungal-peritonitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.99526","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}